Simplex Trading’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Simplex Trading’s Portfolio PHAS Stock Details PHAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,100	Closed	-$4K	–	11606
2022 Q1	$4K	Sell	3,100 -10,500	-77%	-$17K	﹤0.01%	9635
2021 Q4	$35K	Buy	13,600 +5,300	+64%	+$16K	﹤0.01%	7721
2021 Q3	$30K	Hold	8,300	–	–	﹤0.01%	8106
2021 Q2	$30K	Buy	8,300 +8,168	+6,188%	+$27.2K	﹤0.01%	8249
2021 Q1	$45K	Buy	132 +112	+560%	+$455	﹤0.01%	6751
2020 Q4	$6K	Buy	+20	New	+$72	﹤0.01%	7685
2020 Q3	–	Sell	-3	Closed	-$1K	–	8788
2020 Q2	$1K	Buy	+3	New	+$13	﹤0.01%	7450

Other funds holding PHAS

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

HLA

Hamilton Lane Advisors Conshohocken, Pennsylvania $149M AUM 14.17% 1-Year Est. Return

IIA

IPG Investment Advisors San Diego, California $582M AUM 33.22% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Simplex Trading's PHAS Position: Q4 2022 in Review

Simplex Trading sold out of PhaseBio Pharmaceuticals, Inc. Common Stock (PHAS) in Q4 2022, closing a stake of 3,317 shares.

Simplex Trading first reported a position in PHAS in Q2 2020 and held it in 7 quarters. The position peaked at $30K in Q4 2021. 5 funds tracked by Wall St. Rank hold PHAS as of Q4 2022.

Simplex Trading reported no remaining PhaseBio Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Simplex Trading sold 3,317 PhaseBio Pharmaceuticals, Inc. Common Stock shares in Q4 2022.
Simplex Trading first reported a position in PhaseBio Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 7 quarters.
Simplex Trading's PhaseBio Pharmaceuticals, Inc. Common Stock position peaked at $30K in Q4 2021.
5 funds tracked by Wall St. Rank held PhaseBio Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.